ALX Oncology Holdings Inc. (ALXO)
NASDAQ: ALXO · Real-Time Price · USD
1.620
+0.140 (9.46%)
Dec 20, 2024, 4:00 PM EST - Market closed

ALX Oncology Holdings Statistics

Total Valuation

ALXO has a market cap or net worth of $85.44 million. The enterprise value is -$45.77 million.

Market Cap 85.44M
Enterprise Value -45.77M

Important Dates

The last earnings date was Thursday, November 7, 2024, after market close.

Earnings Date Nov 7, 2024
Ex-Dividend Date n/a

Share Statistics

ALXO has 52.74 million shares outstanding. The number of shares has increased by 24.48% in one year.

Current Share Class 52.74M
Shares Outstanding 52.74M
Shares Change (YoY) +24.48%
Shares Change (QoQ) +1.66%
Owned by Insiders (%) 2.14%
Owned by Institutions (%) 49.21%
Float 35.13M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.62
P/TBV Ratio 0.62
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.82, with a Debt / Equity ratio of 0.13.

Current Ratio 4.82
Quick Ratio 4.63
Debt / Equity 0.13
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -93.11

Financial Efficiency

Return on equity (ROE) is -98.94% and return on invested capital (ROIC) is -59.14%.

Return on Equity (ROE) -98.94%
Return on Assets (ROA) -49.24%
Return on Capital (ROIC) -59.14%
Revenue Per Employee n/a
Profits Per Employee -$2.10M
Employee Count 72
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -88.42% in the last 52 weeks. The beta is 1.04, so ALXO's price volatility has been similar to the market average.

Beta (5Y) 1.04
52-Week Price Change -88.42%
50-Day Moving Average 1.49
200-Day Moving Average 6.40
Relative Strength Index (RSI) 52.09
Average Volume (20 Days) 1,376,031

Short Selling Information

The latest short interest is 7.17 million, so 13.60% of the outstanding shares have been sold short.

Short Interest 7.17M
Short Previous Month 7.23M
Short % of Shares Out 13.60%
Short % of Float 20.42%
Short Ratio (days to cover) 8.58

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -159.88M
Pretax Income -166.20M
Net Income -151.16M
EBITDA -159.01M
EBIT -159.88M
Earnings Per Share (EPS) -$2.97
Full Income Statement

Balance Sheet

The company has $148.57 million in cash and $17.36 million in debt, giving a net cash position of $131.22 million or $2.49 per share.

Cash & Cash Equivalents 148.57M
Total Debt 17.36M
Net Cash 131.22M
Net Cash Per Share $2.49
Equity (Book Value) 136.81M
Book Value Per Share 2.59
Working Capital 123.56M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$129.54 million and capital expenditures -$535,000, giving a free cash flow of -$130.08 million.

Operating Cash Flow -129.54M
Capital Expenditures -535,000
Free Cash Flow -130.08M
FCF Per Share -$2.47
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

ALXO does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -24.48%
Shareholder Yield -24.48%
Earnings Yield -176.91%
FCF Yield -152.24%

Analyst Forecast

The average price target for ALXO is $11.00, which is 579.01% higher than the current price. The consensus rating is "Buy".

Price Target $11.00
Price Target Difference 579.01%
Analyst Consensus Buy
Analyst Count 6
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1